Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer now identifies revision v3.8.0 instead of v3.7.2; the page still displays a 403 Forbidden error rather than study details.
    Difference
    0.2%
    Check dated 2026-10-31T15:45:54.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A notice announces that NIH websites are transitioning from the term “Artificial Intelligence” (AI) to “Super Intelligence” (SI), with both terms appearing during the transition.
    Difference
    1%
    Check dated 2026-10-24T18:43:43.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T18:23:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 on a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T19:20:06.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating an access or server issue loading the NCT03420521 page. The visible UI shows a simple header and a Home link, signaling restricted access to study details.
    Difference
    19%
    Check dated 2026-09-19T22:21:38.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.6, indicating a newer version of the page. This update appears to be a maintenance change rather than a modification to study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:29.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.